Search research articles
Contact Us
Filters
Showing results (221-230 of 247) with videos related to
Page
of 25
Sort By:
Cellular & Molecular Immunology
|
January 5, 2022
Enhancing the HSV-1-mediated antitumor immune response by suppressing Bach1
Chaohu Pan, Qiaomei Cai, Xiaorong Li, et al.
Frontiers in Immunology
|
July 12, 2024
Gravidity influences distinct transcriptional profiles of maternal and fetal placental macrophages at term
Nida Ozarslan, Joshua F Robinson, Sirirak Buarpung, et al.
Emerging Microbes & Infections
|
October 19, 2018
Zika virus shedding in the stool and infection through the anorectal mucosa in mice
Chunfeng Li, Yong-Qiang Deng, Shulong Zu, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 21, 2008
Villous B cells of the small intestine are specialized for invariant NK T cell dependence
Peter Velázquez, Bo Wei, Michael McPherson, et al.
Ebiomedicine
|
December 12, 2022
Identification of an immunogenic epitope and protective antibody against the furin cleavage site of SARS-CoV-2
Lili Li, Meiling Gao, Jie Li, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
October 1, 2020
Zika Virus Infection Leads to Variable Defects in Multiple Neurological Functions and Behaviors in Mice and Children
Ziqi Zhao, Ziwei Shang, Zilton Vasconcelos, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 3, 2016
Structural basis for DNA recognition by STAT6
Jing Li, Jose Pindado Rodriguez, Fengfeng Niu, et al.
Ebiomedicine
|
October 17, 2017
Chloroquine, a FDA-approved Drug, Prevents Zika Virus Infection and its Associated Congenital Microcephaly in Mice
Chunfeng Li, Xingliang Zhu, Xue Ji, et al.
Emerging Infectious Diseases
|
January 24, 2023
Early Introduction and Community Transmission of SARS-CoV-2 Omicron Variant, New York, New York, USA
Dakai Liu, Yexiao Cheng, Hangyu Zhou, et al.
Acta Pharmaceutica Sinica. B
|
March 7, 2022
Suppressing fatty acid synthase by type I interferon and chemical inhibitors as a broad spectrum anti-viral strategy against SARS-CoV-2
Saba R Aliyari, Amir Ali Ghaffari, Olivier Pernet, et al.
Page
of 25
Search research articles
Search
Showing results (221-230 of 247) with videos related to
Sort By:
Page
of 25
Cellular & Molecular Immunology
|
January 5, 2022
Enhancing the HSV-1-mediated antitumor immune response by suppressing Bach1
Chaohu Pan, Qiaomei Cai, Xiaorong Li, et al.
Frontiers in Immunology
|
July 12, 2024
Gravidity influences distinct transcriptional profiles of maternal and fetal placental macrophages at term
Nida Ozarslan, Joshua F Robinson, Sirirak Buarpung, et al.
Emerging Microbes & Infections
|
October 19, 2018
Zika virus shedding in the stool and infection through the anorectal mucosa in mice
Chunfeng Li, Yong-Qiang Deng, Shulong Zu, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 21, 2008
Villous B cells of the small intestine are specialized for invariant NK T cell dependence
Peter Velázquez, Bo Wei, Michael McPherson, et al.
Ebiomedicine
|
December 12, 2022
Identification of an immunogenic epitope and protective antibody against the furin cleavage site of SARS-CoV-2
Lili Li, Meiling Gao, Jie Li, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
October 1, 2020
Zika Virus Infection Leads to Variable Defects in Multiple Neurological Functions and Behaviors in Mice and Children
Ziqi Zhao, Ziwei Shang, Zilton Vasconcelos, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 3, 2016
Structural basis for DNA recognition by STAT6
Jing Li, Jose Pindado Rodriguez, Fengfeng Niu, et al.
Ebiomedicine
|
October 17, 2017
Chloroquine, a FDA-approved Drug, Prevents Zika Virus Infection and its Associated Congenital Microcephaly in Mice
Chunfeng Li, Xingliang Zhu, Xue Ji, et al.
Emerging Infectious Diseases
|
January 24, 2023
Early Introduction and Community Transmission of SARS-CoV-2 Omicron Variant, New York, New York, USA
Dakai Liu, Yexiao Cheng, Hangyu Zhou, et al.
Acta Pharmaceutica Sinica. B
|
March 7, 2022
Suppressing fatty acid synthase by type I interferon and chemical inhibitors as a broad spectrum anti-viral strategy against SARS-CoV-2
Saba R Aliyari, Amir Ali Ghaffari, Olivier Pernet, et al.
Page
of 25